Zentalis Pharmaceuticals Inc
(ZNTL)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ZNTL | AZN | AMGN | GILD | VRTX |
| Company | Zentalis Pharmaceuticals Inc | Astrazeneca Plc ADR | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 2.51 | 187.61 | 341.24 | 142.16 | 468.80 |
| High | 2.85 | 190.72 | 349.50 | 145.94 | 476.83 |
| Low | 2.47 | 183.63 | 338.59 | 142.03 | 461.52 |
| Latest | 2.82 | 184.32 | 338.59 | 143.28 | 465.61 |
| Change | +0.31 | -4.09 | -6.09 | +0.39 | -6.40 |
| % Change | +12.35% | -2.17% | -1.77% | +0.27% | -1.36% |
| Volume | 1,127,000 | 2,659,600 | 4,039,900 | 6,840,100 | 1,051,100 |
| 20-Day Average Volume | 2,673,475 | 9,268,380 | 2,855,080 | 7,859,075 | 1,536,330 |
| Previous Close | 2.51 | 188.41 | 344.68 | 142.89 | 472.01 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 2.90 | 102.90 | 337.25 | 130.43 | 464.11 |
| 20-Day Raw Stochastic | 56.20% | 91.84% | 57.41% | 90.40% | 62.56% |
| 20-Day Relative Strength | 58.04 | 88.01 | 53.25 | 70.52 | 53.81 |
| Weighted Alpha | -31.60 | +68.67 | +18.91 | +52.64 | +4.16 |
| Today's Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Previous Opinion | 88% Buy | 100% Buy | 100% Buy | 100% Buy | 88% Buy |
| Last Month's Opinion | 88% Sell | 100% Buy | 96% Buy | 48% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.75% since 01/27/26 | +92.80% since 01/27/26 | -3.62% since 01/27/26 | +1.64% since 01/27/26 | -1.81% since 01/27/26 |
| Low | 2.33 on 01/30/26 | 92.46 on 01/30/26 | 338.07 on 01/30/26 | 138.23 on 01/29/26 | 461.52 on 02/03/26 |
| High | 3.00 on 01/28/26 | 192.79 on 02/02/26 | 351.95 on 01/28/26 | 145.94 on 02/03/26 | 484.35 on 01/29/26 |
| 1-Month | |||||
| %Chg | +105.84% since 01/02/26 | +101.29% since 01/02/26 | +3.34% since 01/02/26 | +17.83% since 01/02/26 | +2.98% since 01/02/26 |
| Low | 1.33 on 01/05/26 | 89.04 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 3.95 on 01/12/26 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 145.94 on 02/03/26 | 487.52 on 01/07/26 |
| 3-Month | |||||
| %Chg | +95.83% since 11/03/25 | +125.55% since 11/03/25 | +14.27% since 11/03/25 | +17.39% since 11/03/25 | +9.30% since 11/03/25 |
| Low | 1.21 on 11/07/25 | 80.48 on 11/04/25 | 294.48 on 11/04/25 | 116.88 on 01/05/26 | 403.16 on 11/04/25 |
| High | 3.95 on 01/12/26 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 145.94 on 02/03/26 | 487.52 on 01/07/26 |
| 6-Month | |||||
| %Chg | +110.45% since 08/01/25 | +149.25% since 08/01/25 | +14.05% since 08/01/25 | +26.59% since 08/01/25 | +0.75% since 08/01/25 |
| Low | 1.21 on 11/07/25 | 72.89 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 362.50 on 08/11/25 |
| High | 3.95 on 01/12/26 | 192.79 on 02/02/26 | 353.25 on 01/27/26 | 145.94 on 02/03/26 | 487.52 on 01/07/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 203,748 | 285,863,360 | 182,324,288 | 177,764,640 | 118,134,096 |
| Shares Outstanding, K | 72,251 | 1,550,908 | 538,481 | 1,240,680 | 253,719 |
| Annual Sales | 67,430,000 | 54,073,000,000 | 33,424,000,000 | 28,754,000,000 | 11,020,100,000 |
| Annual Net Income | -165,840,000 | 7,035,000,000 | 4,090,000,000 | 480,000,000 | -535,600,000 |
| Last Quarter Sales | 0 | 15,191,000,000 | 9,557,000,000 | 7,769,000,000 | 3,076,400,000 |
| Last Quarter Net Income | -26,690,000 | 2,533,000,000 | 3,216,000,000 | 3,052,000,000 | 1,082,900,000 |
| 60-Month Beta | 1.73 | 0.34 | 0.46 | 0.36 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.37 on 11/10/25 | 1.19 on 11/06/25 | 5.29 on 02/03/26 | 2.47 on 10/30/25 | 4.80 on 11/03/25 |
| Latest Earnings Date | 03/25/26 | 02/10/26 | 02/03/26 | 02/10/26 | 02/12/26 |
| Most Recent Dividend | N/A | 0.505 on 08/08/25 | 2.380 on 11/21/25 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 08/08/25 | 02/13/26 | 12/15/25 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.30 | 15.76 | 17.45 | 30.83 |